Journal News

Probing for a ketone body’s link to age-related inflammation

Meric Ozturk
Aug. 24, 2023

Glucose levels in the blood and cells are regulated by the pancreatic hormones insulin and glucagon. While insulin helps cells to take in glucose and reduces blood glucose levels, glucagon initiates the conversion of stored glycogen to glucose.

When glucose is depleted, insulin levels decrease but glucagon levels remain stable. In cells, this triggers the release of fats, which are converted into different types of ketone bodies by the enzyme 3-Hydroxy-3-methylglutaryl-CoA, or HMGCL, in the liver. One of these ketone bodies, beta-hydroxybutyrate, or BHB, can be an energy source for the brain and skeletal muscle when blood glucose is low. Several studies have also shown that BHB also plays a role in the signaling pathways of lipolysis and aging.

Neutrophils are the most abundant type of white blood cells in the human body and play an important role in inflammation.
Neutrophils are the most abundant type of white blood cells in the human body and play an important role in inflammation.

Emily Goldberg, a researcher at the University of California, San Francisco, studies NOD-, LRR- and pyrin domain-containing protein 3, known as NLRP3, and how this protein interacts with BHB. NLRP3 helps to regulate the innate immune system and inflammatory signaling as well as age-related inflammation.

“We had previously shown that the NLRP3 drives age-related inflammation and that the ketone body BHB inhibits NLRP3 activation in macrophages and neutrophils, so we hypothesized that BHB might inhibit age-related inflammation,” Goldberg said.

Although most ketone bodies are produced in liver cells, researchers hypothesize that they also can be synthesized by cells from other tissues, including macrophages and neutrophils.

To test their hypothesis about BHB, Goldberg and a team of researchers from UCSF and the Yale School of Medicine used mice from which they deleted the gene that encodes the HMGCL enzyme. This helped them prevent ketone body synthesis in specific cell types, namely macrophages and neutrophils.

“Making the mice to test this hypothesis and planning the experiments to have enough aged mice was the most difficult part of the study,” Goldberg said.

The team compared the role of liver-based ketone body formation with that of cell-specific ketone body formation in age-related inflammation.

In their recent paper published in the Journal of Biological Chemistry, the researchers point out that the liver is the only organ that can produce enough ketone bodies to maintain blood glucose levels, and neutrophil-based ketogenesis does not regulate age-related metabolic health.

“Exogenous ketones are likely responsible for controlling innate immune inflammation in aging,” Goldberg said, “Macrophages can metabolize acetoacetate, but not BHB and this is important for their function. But why innate immune cells take up BHB remains unclear.”

The group only used a single mouse strain; using other strains and different mutations in different enzymes in the ketone body formation pathway could show different results. Goldberg said that next they will consider all these limitations and aim to determine why innate immune cells take up BHB.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Meric Ozturk

Meric Ozturk is a Ph.D. student in biochemistry at Iowa State University and an ASBMB Today volunteer contributor.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

How scientists identified a new neuromuscular disease
Feature

How scientists identified a new neuromuscular disease

Aug. 14, 2025

NIH researchers discover Morimoto–Ryu–Malicdan syndrome, after finding shared symptoms and RFC4 gene variants in nine patients, offering hope for faster diagnosis and future treatments.

Unraveling cancer’s spaghetti proteins
Profile

Unraveling cancer’s spaghetti proteins

Aug. 13, 2025

MOSAIC scholar Katie Dunleavy investigates how Aurora kinase A shields oncogene c-MYC from degradation, using cutting-edge techniques to uncover new strategies targeting “undruggable” molecules.

How HCMV hijacks host cells — and beyond
Profile

How HCMV hijacks host cells — and beyond

Aug. 12, 2025

Ileana Cristea, an ASBMB Breakthroughs webinar speaker, presented her research on how viruses reprogram cell structure and metabolism to enhance infection and how these mechanisms might link viral infections to cancer and other diseases.

Understanding the lipid link to gene expression in the nucleus
Profile

Understanding the lipid link to gene expression in the nucleus

Aug. 11, 2025

Ray Blind, an ASBMB Breakthroughs speaker, presented his research on how lipids and sugars in the cell nucleus are involved in signaling and gene expression and how these pathways could be targeted to identify therapeutics for diseases like cancer.

Receptor antagonist reduces age-related bone loss in mice
Journal News

Receptor antagonist reduces age-related bone loss in mice

Aug. 6, 2025

Receptor antagonist reduces bone loss and promotes osteoblast activity in aging mice, highlighting its potential to treat osteoporosis. Read more about this recent JBC paper.

Engineered fusion protein targets kiwifruit pathogen
Journal News

Engineered fusion protein targets kiwifruit pathogen

Aug. 6, 2025

Synthetic protein selectively kills kiwifruit pathogen, offering a promising biocontrol strategy for agriculture. Read more about this recent JBC paper.